National Bank of Canada FI Sells 356,165 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

National Bank of Canada FI reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 34.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 690,249 shares of the healthcare conglomerate's stock after selling 356,165 shares during the quarter. National Bank of Canada FI owned about 0.08% of UnitedHealth Group worth $349,175,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. NewSquare Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $25,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $30,000. Promus Capital LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $32,000. Pillar Financial Advisors LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $40,000. Finally, DecisionPoint Financial LLC raised its holdings in UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock worth $52,000 after purchasing an additional 62 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Up 0.1 %

Shares of NYSE:UNH traded up $0.49 during midday trading on Wednesday, hitting $523.61. The stock had a trading volume of 2,368,702 shares, compared to its average volume of 4,265,457. The company has a market cap of $478.95 billion, a P/E ratio of 33.78, a PEG ratio of 1.37 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business's 50-day simple moving average is $509.06 and its 200-day simple moving average is $542.96. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group's quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.83 EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.60%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is 54.19%.

Wall Street Analyst Weigh In

Several analysts recently commented on UNH shares. Stephens raised their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a research note on Thursday, December 5th. Barclays decreased their price objective on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday, January 17th. Piper Sandler cut their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research note on Thursday, January 2nd. Hsbc Global Res upgraded shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. Finally, Oppenheimer increased their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a report on Friday, December 6th. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Buy" and an average price target of $629.32.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm's stock in a transaction dated Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.